Molecular Adjuvant Potential of and in Starry Flounder Challenged with .

Animals (Basel)

Department of Marine Biology & Aquaculture, College of Marine Science, Gyeongsang National University, 455, Tongyeong 650-160, Republic of Korea.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In fish, the innate immune system is crucial for rapid defense against pathogens. In this study, we performed transcriptome sequencing using next-generation sequencing (NGS) to identify and characterize granulocyte colony-stimulating factor () and macrophage colony-stimulating factor () in starry flounder (). The gene (594 bp, 198 aa) features a conserved IL-6 domain, while the gene (621 bp, 207 aa) contains a predicted transmembrane region. Phylogenetic analysis confirmed high evolutionary conservation with other marine species. Quantitative real-time PCR revealed that is highly expressed in the skin, peripheral blood leukocytes, and muscle, with significant up-regulation in immune organs following infection; exhibited a similar tissue-specific expression pattern. Recombinant () was produced using a cell-free system and effectively enhanced leukocyte phagocytic activity at an optimal concentration of 150 μg/mL, without causing cytotoxicity in hemolytic assays. In contrast, exhibited folding issues during purification. These findings highlight the potential of as a molecular adjuvant to enhance immune responses in aquaculture. This study provides foundational knowledge for developing cytokine-based adjuvants, which could reduce antibiotic dependency and enhance vaccine efficacy in sustainable aquaculture systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12248607PMC
http://dx.doi.org/10.3390/ani15131848DOI Listing

Publication Analysis

Top Keywords

molecular adjuvant
8
starry flounder
8
colony-stimulating factor
8
adjuvant potential
4
potential starry
4
flounder challenged
4
challenged fish
4
fish innate
4
innate immune
4
immune system
4

Similar Publications

Introduction Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before the age of 50, has exhibited a sustained increase in incidence globally. In Mexico, this rising trend presents significant clinical and diagnostic challenges, particularly in younger patients who often lack traditional risk factors. This study aimed to describe and compare the epidemiological, clinical, histopathological, and therapeutic characteristics of EOCRC versus late-onset colorectal cancer (LOCRC) in a referral hospital in Mexico City.

View Article and Find Full Text PDF

Hyaluronic acid promotes biomineralization of osteoblast-like cells - observations on two different barrier membranes.

Int J Implant Dent

September 2025

Department of Periodontology, Center for Biomedical Education and Research (ZBAF), School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Background: Guided bone regeneration (GBR) relies on biocompatible membranes to support osteogenesis. 1,4-butanediol diglycidyl ether (BDDE)-crosslinked hyaluronic acid (xHyA) has shown promise in enhancing bone regeneration, yet its mechanisms remain unclear.

Objective: This study evaluates the osteogenic effects of xHyA-functionalized native pericardium collagen membrane (NPCM) and ribose-crosslinked collagen membrane (RCCM) using an airlift culture model with SaOS-2 cells.

View Article and Find Full Text PDF

Despite advances in antiretroviral therapy, HIV-1 persistence and immune dysregulation remain unresolved challenges. Here, we demonstrate that curcumin, a low-toxicity natural compound, can inhibit HIV-1 through simultaneous inhibition of the PI3K/AKT and JAK/STAT pathways, leading to downregulation of the viral co-receptor CCR5 and the immune checkpoint transcription factor FOXP3. Using CHIP and EMSA experiments, we found that curcumin disrupts the binding of FOXP3 to the CCR5 promoter, thereby reducing viral entry.

View Article and Find Full Text PDF

Outer membrane vesicle-coated ferrocene nanoparticles induce dual ferroptosis for cancer immunotherapy.

J Control Release

September 2025

School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China. Electronic address:

Fusobacterium nucleatum (Fn.) can colonize breast cancer tissue to promote tumor progression by inducing immunosuppression. Targeted therapeutic strategies against intratumoral bacteria remain unexplored and have potential in tumor immunotherapy.

View Article and Find Full Text PDF

Background: The PORTEC-3 trial investigated the benefit of chemoradiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We present the preplanned long-term analysis of the randomised PORTEC-3 trial with a post-hoc analysis including molecular classification of the tumours.

Methods: PORTEC-3 was an open-label, multicentre, randomised, international phase 3 trial.

View Article and Find Full Text PDF